纤维蛋白原βG-455A基因多态性与血浆纤维蛋白原及冠心病的关系Association of fibrinogen βG-455A polymorphism with plasma fibrinogen level in patients with coronary heart disease
马会利,刘鸣,孙爱军,陈纪林,王颖,王箴,王克强,黄薇,邹云增,葛均波
摘要(Abstract):
目的研究中国人群中纤维蛋白原βG-455A基因多态性与血浆纤维蛋白原水平及冠心病亚型的关系。方法1 485例因胸痛或非侵入性检查提示心肌缺血的成年人进行了冠状动脉造影检查,根据临床表现及冠状动脉造影结果被分为冠心病组(n=1 019)及对照组(n=466),冠心病组又被分为稳定型心绞痛(SAP)组(n=674)及急性冠状动脉综合征(ACS)组(n=345)。应用vonClauss法测定血浆纤维蛋白原水平,多聚酶链反应(PCR)和HaeⅢ内切酶技术检测纤维蛋白原βG-455A基因多态性。结果ACS组及SAP组的血浆纤维蛋白原水平较对照组显著升高,其中ACS组最高(ACS组380.92±92.35 mg/dL,SAP组352.49±94.89 mg/dL,对照组311.72±87.09 mg/dL,三组之间两两比较,P均<0.001)。在对照组及SAP组中基因型为AA的纯合子其血浆纤维蛋白原水平较携带G等位基因的个体为高(对照组AA为363.83±76.66 mg/dL,与GA的337.83±77.43mg/dL或GG的295.28±88.06 mg/dL比较,P均<0.05;SAP组AA为429.82±93.35 mg/dL,与GA的368.30±90.39 mg/dL或GG的337.89±94.32 mg/dL比较,P均<0.05),而在ACS组未见此趋势。各组之间的基因型及等位基因频率分布差异无统计学意义(P>0.05),-455A等位基因与冠心病发病风险无相关性。结论血浆纤维蛋白原水平升高与冠心病发病风险相关。纤维蛋白原βG-455A基因多态性与冠心病发病无相关性。
关键词(KeyWords): 等位基因;纤维蛋白原;冠状动脉疾病;心绞痛
基金项目(Foundation): 863计划(2006AA02A406)冠心病的分子分型及个体化治疗研究;; 973计划(2006CB503803)重大血管性疾病发病机制和防治的基础研究
作者(Author): 马会利,刘鸣,孙爱军,陈纪林,王颖,王箴,王克强,黄薇,邹云增,葛均波
参考文献(References):
- [1]Hamsten A,Blomback M,Iselius L,et al.Genetic and culturalinheritance of plasma fibrinogen concentration.Lancet,1987,2:988-991.
- [2]Humphries S,Henry J,Montgomery H.Gene-environment inter-action in the determination of levels of haemostatic variables in-volved in thrombosis and fibrinolysis.Blood Coagul Fibrinolysis,1999,10:S17-S21.
- [3]Smith GD,Harbord R,Milton J,et al.Does elevated plasma fi-brinogen increase the risk of coronary heart disease?Evidencefrom a meta-analysis of genetic association studies.ArteriosclerThromb Vasc Biol,2005,25:2228-2233.
- [4]Behague I,Poirer O,Nicaud V,et al.Fibrinogen gene polymor-phisms are associated with plasma fibrinogen and coronary arterydisease in patients with myocardial infarction.Circulation,1996,93:440-449.
- [5]Gardemann A,Schwartz O,Haberbosch W,et al.Positive asso-ciation of the beta fibrinogen H1/H2 gene variation to basal fi-brinogen levels and to the increase in fibrinogen concentrationduring acute phase reaction but not to coronary artery disease andmyocardial infarction.Thromb Haemost,1997,77:1120-1126.
- [6]Lee AJ,Fowkes FGR,Lowe GDO,et al.Fibrinogen,factor VIIand OAI-1 genotypes and the risk of coronary and peripheral ath-erosclerosis:Edinburgh Artery Study.Thromb Haemost,1999,81:553-560.
- [7]Doggen CJM,Bertina RM,Manger Cats V,et al.Fibrinogenpolymorphisms are not associated with the risk of myocardial in-farction.Br J Haematol,2000,110:935-938.
- [8]Leander K,Wiman B,Hallqvist J,et al.The G-455A polymor-phism of the fibrinogen Bβ-gene relates to plasma fibrinogen inmale cases,but does not interact with environmental factors incausing myocardial infarction in either men or women.J Int Med,2002,252:332-341.
- [9]马会利,陈纪林.β纤维蛋白原基因启动子区HaeⅢ多态性和血浆纤维蛋白原浓度与冠心病的相关性研究.中华心血管病杂志,1999,27:277-279.
- [10]Anne Tybjerg-Hansen,Birgit Agerholm-Larsen,Steve E.Hum-phries,et al.Acommon mutation(G-455→A)in the-fibrinogenpromoter is an independent predictor of plasma fibrinogen,butnot of ischemic heart disease.A study of9 127 individuals basedon the copenhagen city heart study.J Clin Invest,1997,99:3034-3039.
- [11]龚五星,蔡月明,彭健,等.冠心病患者纤维蛋白原Bβ启动区基因多态性.中国动脉硬化杂志,2002,10:140-143.
- [12]王爱玲,余元勋,徐岩,等.β纤维蛋白原基因2455G/A多态性与急性心肌梗死的关系.安徽医科大学学报,2005,40:238-240.
- [13]Leanderi K,Wiman B,Hallqvist J,et al.The G-455Apolymor-phism of the fibrinogen Bb-gene relates to plasma fibrinogen inmale cases,but does not interact with environmental factors incausing myocardial infarction in either men or women.J InternMed,2002,252:332-341.
- [14]Folsom A R,Aleksic N,Ahn C.Beta-fibrinogen gene 2455G/Apolymorphism and coronary heart disease incidence:The athero-sclerosis risk in communities(ARIC)study.Ann Epidemiol,2001,11:166-170.
- [15]van der Bom J G,de Maat MPM,Bots ML,et al.Elevated plas-ma fibrinogen cause or consequence of cardiovascular disease?Arterioscler Thromb Vasc Biol,1998,18:621-625.